• City of Hope dedicates Gonda Expansion building
• Blood protein may indicate chances of successful liver transplant for some patients
• Scientists show protein may predict colorectal cancer survival and could help guide treatment
• Food and wine aficionados raise $108,000 at Northern California Taste of Hope event
• Fundraising walks boost funding, awareness for fight against women’s cancers
• Administrative professionals to be honored in April

 
Technology sharing

From right, Hiromitsu Iwata, M.D., Ph.D., Eri Oshima, M.D., and Takeshi Yanagi, M.D., Ph.D., listen to Jeffrey Wong, M.D., chair of the Department of Radiation Oncology, explain therapeutic radiation dosing possible through total marrow irradiation (TMI) as City of Hope’s An Liu, Ph.D., observes.

The physicians, all radiation oncologists from Nagoya, Japan, visited City of Hope on March 9 to learn about City of Hope’s use of TomoTherapy for TMI, which is in clinical trials as part of hematopoietic cell transplant regimens. TMI, pioneered at City of Hope, allows physicians to focus higher doses of radiation specifically to marrow, sparing healthy tissue and potentially reducing side effects. (Photo by Alicia Di Rado)